Multiple sclerosis directly affects the brain. It is, at its core, a brain and spinal cord disease. The immune system attacks the protective coating around nerve fibers in the central nervous system, creating areas of damage called lesions that disrupt how signals travel through the brain. Over time, this process can shrink brain tissue, slow thinking, and produce a wide range of neurological symptoms depending on where the damage occurs.
How MS Damages Brain Tissue
In MS, certain immune cells that normally fight infections cross from the bloodstream into the brain, where they shouldn’t be. Once inside, they target myelin, the insulating layer that wraps around nerve fibers and helps electrical signals travel quickly and efficiently. These immune cells release inflammatory substances that break down the myelin sheath, a process called demyelination.
When myelin is stripped away, nerve signals slow down or get blocked entirely. Think of it like damaged insulation on an electrical wire: the signal still tries to travel, but it’s weaker, slower, or gets lost. The exposed nerve fiber can sometimes adapt temporarily by rearranging its ion channels to keep conducting signals. But if the myelin stays damaged for too long, the nerve fiber itself degenerates. That’s when damage becomes permanent.
This is why early treatment matters so much. The goal is to stop the immune attack before exposed nerve fibers are lost for good.
Where Lesions Form in the Brain
MS lesions tend to appear in specific locations. Diagnostic criteria require lesions in at least two of four characteristic areas: near the brain’s fluid-filled ventricles (periventricular), near the outer cortex (juxtacortical), in the brainstem or cerebellum (infratentorial), or in the spinal cord. These locations are so consistent that MRI scans targeting these regions are central to how MS is diagnosed.
The symptoms you experience depend heavily on where lesions land. Lesions near the ventricles often affect thinking and memory. Lesions in the brainstem can cause vertigo, double vision, abnormal eye movements, difficulty swallowing, slurred speech, and facial numbness. Abnormal eye movements are one of the most common findings when brainstem lesions are present, occurring in roughly 45% of MS patients with damage in that area. Lesions in the cerebellum affect balance and coordination, causing unsteady walking or difficulty with fine motor tasks.
White Matter and Gray Matter
MS was long considered primarily a white matter disease, since the myelin-covered nerve fibers that make up white matter are the obvious targets. White matter lesions remain the main imaging marker used to track disease activity and are built into diagnostic criteria and treatment goals.
But MS also damages gray matter, the brain tissue that contains the cell bodies of neurons. Gray matter volumes are measurably lower in people with MS than in healthy individuals, and this shrinkage can appear very early, sometimes even predicting who will progress from a first neurological episode to a full MS diagnosis. What makes gray matter atrophy particularly important is its connection to cognitive problems. Gray matter loss correlates more strongly with cognitive decline than white matter lesion volume does.
Brain Shrinkage Over Time
Everyone loses a small amount of brain volume as they age. In healthy adults, the brain shrinks at roughly 0.27% per year. In people with MS, that rate nearly doubles to about 0.51% per year. That difference adds up. Over a decade, a person with MS may lose roughly 2.4% more brain volume than someone without the disease, contributing to worsening disability and cognitive changes.
Brain atrophy in MS is driven by both the acute inflammatory attacks and a slower, more gradual neurodegenerative process. This is why people with progressive forms of MS can continue to worsen even when new visible lesions stop appearing on MRI. The damage isn’t only about new flare-ups. It’s also about the slow loss of neurons over time.
Cognitive Effects
Cognitive impairment affects up to 65% of people with MS at some point during the disease. It can appear at any stage, including very early. Among people with a first isolated episode, roughly 20 to 25% already show measurable cognitive changes. That rises to 30 to 45% in relapsing-remitting MS and 50 to 75% in secondary progressive MS.
The cognitive domains hit hardest are information processing speed (how quickly you can take in and respond to information), learning and memory, visual-spatial abilities, and executive function (planning, organizing, and mental flexibility). In a study of over 1,200 MS patients, researchers identified five distinct cognitive profiles. About 19% had fully preserved cognition, while around 18% had severe impairment across multiple domains. The largest group, nearly 30%, showed mild difficulty with verbal memory and word-finding.
These changes often show up in everyday life as difficulty following conversations in noisy environments, trouble multitasking, forgetting appointments, or struggling to find the right word. They can be subtle enough that standard neurological exams miss them, which is why specialized cognitive testing is valuable for catching problems early.
Relapsing vs. Progressive MS
The two main patterns of MS, relapsing-remitting and primary progressive, both affect the brain, but the balance between inflammation and degeneration differs. Relapsing-remitting MS tends to produce more white matter lesions overall. Primary progressive MS typically has fewer visible lesions on MRI but features more steady, gradual neurodegeneration.
Despite these differences, the underlying lesion biology looks remarkably similar. When researchers examined the characteristics of white matter lesions in both subtypes, around 68% of lesions in primary progressive MS and 74% in relapsing-remitting MS shared the same structural features, with no statistically significant difference between them. This reinforces that both forms involve the same core disease process in the brain, just with different balances of inflammation and slow tissue loss.
How the Brain Compensates
The brain has a surprising ability to work around MS damage, at least for a while. Functional brain imaging shows that people with MS often activate larger areas of their brain to perform the same tasks that healthy individuals complete with smaller, more focused activation. The brain essentially recruits backup regions to pick up the slack when primary pathways are damaged.
This compensatory process, known as functional reorganization, helps explain why some people maintain normal performance on cognitive and physical tasks despite having significant lesion burden on their MRI. It also explains why MS can seem to suddenly worsen: once the brain runs out of reserve capacity to compensate, even a small amount of new damage can push someone past a tipping point.
Can the Brain Repair Itself?
The brain does attempt to repair myelin damage through a process called remyelination. Precursor cells in the brain can migrate to damaged areas, mature into myelin-producing cells, and rewrap exposed nerve fibers. When this works, nerve conduction improves and symptoms can partially or fully recover, which is what happens during remission after a relapse.
The problem is that remyelination often fails or remains incomplete. The repair process requires precursor cells to arrive at the right location, mature properly, and interact with the nerve fiber to rebuild the sheath. In MS, the ongoing inflammatory environment and repeated injury can overwhelm this repair capacity. When remyelination fails and nerve fibers stay exposed too long, irreversible nerve fiber degeneration follows, leading to permanent disability. Boosting the brain’s natural repair process remains one of the most active areas of MS treatment development.